Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $6.43 billion. The enterprise value is $6.33 billion.
| Market Cap | 6.43B |
| Enterprise Value | 6.33B |
Important Dates
The last earnings date was Tuesday, July 29, 2025, after market close.
| Earnings Date | Jul 29, 2025 |
| Ex-Dividend Date | Aug 11, 2025 |
Share Statistics
Chemed has 14.52 million shares outstanding. The number of shares has decreased by -2.35% in one year.
| Current Share Class | 14.52M |
| Shares Outstanding | 14.52M |
| Shares Change (YoY) | -2.35% |
| Shares Change (QoQ) | -0.41% |
| Owned by Insiders (%) | 1.53% |
| Owned by Institutions (%) | 96.10% |
| Float | 14.28M |
Valuation Ratios
The trailing PE ratio is 22.75 and the forward PE ratio is 18.46. Chemed's PEG ratio is 2.05.
| PE Ratio | 22.75 |
| Forward PE | 18.46 |
| PS Ratio | 2.61 |
| Forward PS | 2.42 |
| PB Ratio | 5.37 |
| P/TBV Ratio | 14.48 |
| P/FCF Ratio | 17.32 |
| P/OCF Ratio | 15.07 |
| PEG Ratio | 2.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.58, with an EV/FCF ratio of 17.04.
| EV / Earnings | 21.80 |
| EV / Sales | 2.52 |
| EV / EBITDA | 14.58 |
| EV / EBIT | 16.89 |
| EV / FCF | 17.04 |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.86 |
| Quick Ratio | 1.65 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.29 |
| Debt / FCF | 0.39 |
| Interest Coverage | 220.65 |
Financial Efficiency
Return on equity (ROE) is 24.14% and return on invested capital (ROIC) is 17.36%.
| Return on Equity (ROE) | 24.14% |
| Return on Assets (ROA) | 13.56% |
| Return on Invested Capital (ROIC) | 17.36% |
| Return on Capital Employed (ROCE) | 25.77% |
| Revenue Per Employee | $160,046 |
| Profits Per Employee | $18,499 |
| Employee Count | 15,695 |
| Asset Turnover | 1.45 |
| Inventory Turnover | 167.65 |
Taxes
In the past 12 months, Chemed has paid $97.60 million in taxes.
| Income Tax | 97.60M |
| Effective Tax Rate | 25.16% |
Stock Price Statistics
The stock price has decreased by -23.60% in the last 52 weeks. The beta is 0.46, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | -23.60% |
| 50-Day Moving Average | 491.76 |
| 200-Day Moving Average | 547.65 |
| Relative Strength Index (RSI) | 43.60 |
| Average Volume (20 Days) | 187,739 |
Short Selling Information
The latest short interest is 384,385, so 2.65% of the outstanding shares have been sold short.
| Short Interest | 384,385 |
| Short Previous Month | 431,352 |
| Short % of Shares Out | 2.65% |
| Short % of Float | 2.69% |
| Short Ratio (days to cover) | 1.93 |
Income Statement
In the last 12 months, Chemed had revenue of $2.51 billion and earned $290.35 million in profits. Earnings per share was $19.48.
| Revenue | 2.51B |
| Gross Profit | 845.22M |
| Operating Income | 374.66M |
| Pretax Income | 387.17M |
| Net Income | 290.35M |
| EBITDA | 434.17M |
| EBIT | 374.66M |
| Earnings Per Share (EPS) | $19.48 |
Balance Sheet
The company has $249.90 million in cash and $145.56 million in debt, giving a net cash position of $104.34 million or $7.19 per share.
| Cash & Cash Equivalents | 249.90M |
| Total Debt | 145.56M |
| Net Cash | 104.34M |
| Net Cash Per Share | $7.19 |
| Equity (Book Value) | 1.20B |
| Book Value Per Share | 82.56 |
| Working Capital | 227.49M |
Cash Flow
In the last 12 months, operating cash flow was $426.78 million and capital expenditures -$55.39 million, giving a free cash flow of $371.39 million.
| Operating Cash Flow | 426.78M |
| Capital Expenditures | -55.39M |
| Free Cash Flow | 371.39M |
| FCF Per Share | $25.58 |
Margins
Gross margin is 33.65%, with operating and profit margins of 14.92% and 11.56%.
| Gross Margin | 33.65% |
| Operating Margin | 14.92% |
| Pretax Margin | 15.44% |
| Profit Margin | 11.56% |
| EBITDA Margin | 17.28% |
| EBIT Margin | 14.92% |
| FCF Margin | 14.79% |
Dividends & Yields
This stock pays an annual dividend of $2.40, which amounts to a dividend yield of 0.54%.
| Dividend Per Share | $2.40 |
| Dividend Yield | 0.54% |
| Dividend Growth (YoY) | 23.53% |
| Years of Dividend Growth | 16 |
| Payout Ratio | 10.78% |
| Buyback Yield | 2.35% |
| Shareholder Yield | 2.89% |
| Earnings Yield | 4.51% |
| FCF Yield | 5.77% |
Analyst Forecast
The average price target for Chemed is $579.75, which is 30.83% higher than the current price. The consensus rating is "Buy".
| Price Target | $579.75 |
| Price Target Difference | 30.83% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 14.38 and a Piotroski F-Score of 6.
| Altman Z-Score | 14.38 |
| Piotroski F-Score | 6 |